Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.

Biotechnology

Education

Sonoma Biotherapeutics

Sonoma Biotherapeutics' headquarters in South San Francisco, CA, United States

Jeff Bluestone

Katherine Galindo

Anavelys Ortiz-Suarez

Stacey Delaney

Joe Arron

Jimmy Chung

Melisa S. Medrano

Jessica Stitt

Fred Ramsdell

Rick Klausner

John C Davis

Katina Dorton

Frank Yu

Maggie Wilderotter

Toni Hoover

Terry Rosen

John C. Davis Jr.

Description

People (3)

Jeff Bluestone

Terry Rosen

Jennifer Abrams

Jobs